CoChat
Sign Up
Cited by 59

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3

Shan, Zheng-nan, Tian, Rui, Zhang, Min, Gui, Zhao-hua, Wu, Jing, Ding, Min, Zhou, Xin-Fu, He, Jie·2016·Oncotarget
DOI 10.18632/oncotarget.12385PMC PMC5346679
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.12385

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Up-regulation of miR-128-3p profoundly reduces the expression of core protein components of PRC1 and PRC2: BMI-1 and SUZ12, respectively.

    “Several studies showed that up-regulation of miR-128-3p profoundly reduced the expression of core protein components of PRC1 and PRC2: BMI-1 (Polycomb complex protein BMI-1)77,126,127 and SUZ12 (Polycomb protein SUZ12),77,128,129 respectively.”

    From MiR-128-3p – a gray eminence of the human central nervous system (2024) · cites this paper as [127]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 34

  1. McCarthy, 2001, Current epidemiological trends and surveillance issues in brain tumors, Expert Rev Anticancer Ther, 1, 395, 10.1586/14737140.1.3.395 · DOI
  2. Reynolds, 2006, Brain tumour stem cells, Nat Rev Cancer, 6, 425, 10.1038/nrc1889 · DOI
  3. Dirks, 2004, Cancer stem cells in nervous system tumors, Oncogene, 23, 7267, 10.1038/sj.onc.1207946 · DOI · Paper page
  4. Vescovi, 2006, Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells, Nature, 444, 761, 10.1038/nature05349 · DOI
  5. Maniatis, 2008, Multilevel regulation of gene expression by microRNAs, Science, 319, 1789, 10.1126/science.1152326 · DOI
  6. Bartel, 2009, MicroRNAs: target recognition and regulatory functions, Cell, 136, 215, 10.1016/j.cell.2009.01.002 · DOI · Paper page
  7. Slack, 2006, Oncomirs - microRNAs with a role in cancer, Nat Rev Cancer, 6, 259, 10.1038/nrc1840 · DOI
  8. Lawler, 2008, Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal, Cancer Res, 68, 9125, 10.1158/0008-5472.CAN-08-2629 · DOI · Paper page
  9. Farace, 2005, Extensive modulation of a set of microRNAs in primary glioblastoma, Biochem Biophys Res Commun, 334, 1351, 10.1016/j.bbrc.2005.07.030 · DOI · Paper page
  10. Cho, 2013, Immunological characterization of glioblastoma cells for immunotherapy, Anticancer Res, 33, 2525
  11. Lawler, 2010, MicroRNAs and glioblastoma; the stem cell connection, Cell Death Differ, 17, 221, 10.1038/cdd.2009.71 · DOI · Paper page
  12. Doki, 2014, Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer, Ann Surg Oncol, 21, 205, 10.1245/s10434-013-3264-3 · DOI
  13. Sawalha, 2014, Genome-wide DNA methylation study identifies significant epigenomic changes in osteoarthritic cartilage, Arthritis Rheumatol, 66, 2804, 10.1002/art.38762 · DOI
  14. Tang, 2014, miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells, Cancer Res, 74, 4183, 10.1158/0008-5472.CAN-14-0404 · DOI
  15. Temple, 2007, shRNA knockdown of Bmi-1 reveals a critical role for p21-Rb pathway in NSC self-renewal during development, Cell Stem Cell, 1, 87, 10.1016/j.stem.2007.04.001 · DOI
  16. Arsenijevic, 2005, Bmi1 loss produces an increase in astroglial cells and a decrease in neural stem cell population and proliferation, J Neurosci, 25, 5774, 10.1523/JNEUROSCI.3452-04.2005 · DOI
  17. Peng, 2009, MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a, J Mol Med (Berl), 87, 43, 10.1007/s00109-008-0403-6 · DOI · Paper page
  18. Godlewski, 2013, MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells, Neuro Oncol, 15, 1212, 10.1093/neuonc/not055 · DOI · Paper page
  19. Wilkinson, 2011, Identification of a microRNA that activates gene expression by repressing nonsense-mediated RNA decay, Mol Cell, 42, 500, 10.1016/j.molcel.2011.04.018 · DOI
  20. Bartel, 2005, Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes, RNA, 11, 241, 10.1261/rna.7240905 · DOI · Paper page
  21. Espinosa-Parrilla, 2010, Design and evaluation of a panel of single-nucleotide polymorphisms in microRNA genomic regions for association studies in human disease, Eur J Hum Genet, 18, 218, 10.1038/ejhg.2009.165 · DOI
  22. Zhu, 2012, Loss of SNAIL regulated miR-128-2 on chromosome 3p22. 3 targets multiple stem cell factors to promote transformation of mammary epithelial cells, Cancer Res, 72, 6036, 10.1158/0008-5472.CAN-12-1507 · DOI
  23. Davidson, 2010, Structure and activity of putative intronic miRNA promoters, RNA, 16, 495, 10.1261/rna.1731910 · DOI · Paper page
  24. Michalek, 2009, MicroRNA involvement in glioblastoma pathogenesis, Biochem Biophys Res Commun, 386, 1, 10.1016/j.bbrc.2009.06.034 · DOI
  25. Ng, 2009, Oncogenic role of microRNAs in brain tumors, Acta Neuropathol, 117, 599, 10.1007/s00401-009-0525-0 · DOI · Paper page
  26. Weber, 2005, The role of radio- and chemotherapy in glioblastoma, Onkologie, 28, 315
  27. Parada, 2012, Malignant glioma: lessons from genomics, mouse models, and stem cells, Cell, 149, 36, 10.1016/j.cell.2012.03.009 · DOI
  28. Quinones-Hinojosa, 2012, Stem cells in gliomas, Handb Clin Neurol, 104, 63, 10.1016/B978-0-444-52138-5.00006-2 · DOI
  29. Jones, 2007, Epigenetics and microRNAs, Pediatr Res, 61, 24r, 10.1203/pdr.0b013e3180457684 · DOI
  30. Jones, 2006, Epigenetic activation of tumor suppressor microRNAs in human cancer cells, Cell Cycle, 5, 2220, 10.4161/cc.5.19.3340 · DOI
  31. Li, 2013, miR-128 and its target genes in tumorigenesis and metastasis, Exp Cell Res, 319, 3059, 10.1016/j.yexcr.2013.07.031 · DOI
  32. van Lohuizen, 2006, Polycomb silencers control cell fate, development and cancer, Nat Rev Cancer, 6, 846, 10.1038/nrc1991 · DOI
  33. Parissenti, 2010, Comparison of bisulfite sequencing PCR with pyrosequencing for measuring differences in DNA methylation, Anal Biochem, 397, 96, 10.1016/j.ab.2009.10.021 · DOI
  34. Bao, 2011, Elevated invasive potential of glioblastoma stem cells, Biochem Biophys Res Commun, 406, 643, 10.1016/j.bbrc.2011.02.123 · DOI

Cited by

Sorted by citations

Metadata

Authors
Shan, Z.-N., Tian, R., Zhang, M., Gui, Z.-H., Wu, J., Ding, M., Zhou, X.-F., & He, J.
Affiliations
  • Department of Pathology, Anhui Provincial Hospital affiliated to Anhui Medical University and Anhui Provincial Cancer Hospital, Hefei 230031, China
  • School of Pharmacy and Medical Sciences, Faculty of Health Sciences, University of South Australia, Adelaide SA 5000, Australia
Venue
Oncotarget
Publisher
Impact Journals, LLC
Published
2016-10-01
Volume
7
Issue
48
Pages
78813-78826
ISSN
1949-2553
DOI
10.18632/oncotarget.12385
PMC
PMC5346679
Cited by
59
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review